Literature DB >> 180937

Biochemical abnormalities of erythrocyte membranes in Duchenne dystrophy. Adenosine triphosphatase and adenyl cyclase.

S Mawatari, M Schonberg, M Olarte.   

Abstract

Adenosine triphosphatase (ATPase) activity in erythrocyte membranes from patients with Duchenne dystrophy was inhibited by ouabain less than in normal individuals in assay systems containing high or low contents of salt. Epinephrine and cyclic adenosine monophosphate increased total ATPase activity in all samples, and epinephrine restored ouabain sensitivity to the Duchenne membranes. Basal adenyl cyclase activity in about twice that of controls. Epinephrine stimulated adenyl cyclase activity of normal membranes two to three times, but did not stimulate the enzyme in Duchenne membranes. These differences may reflect a genetic abnormality of the membrane.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180937     DOI: 10.1001/archneur.1976.00500070031006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

1.  Erythrocyte membrane abnormalities in Duchenne muscular dystrophy monitored by saturation transfer electron paramagnetic resonance spectroscopy.

Authors:  L S Wilkerson; R C Perkins; R Roelofs; L Swift; L R Dalton; J H Park
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

Review 2.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Erythrocyte ghost (Na+ + K+) ATPase activity in mice with hereditary muscular dystrophy (strain C57 BL/64J/dy).

Authors:  G Souweine; M O Rolland; I Maire; M C Donas
Journal:  J Neurol       Date:  1978-02-14       Impact factor: 4.849

4.  Incorporation of amino acids into soluble and membrane protein fractions of dystrophic hamsters.

Authors:  D M Nicholls; R C Creasy; M W Chin-See; J A Carlisle; A B Lange; M Saleem
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

5.  Skeletal-muscle sarcolemma from normal and dystrophic mice. Isolation, characterization and lipid composition.

Authors:  T A de Kretser; B G Livett
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

6.  The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution.

Authors:  Y Dalmaz; L Peyrin; J C Mamelle; D Tuil; R Gilly; J F Cier
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Structural changes in lysosomes from cultured human fibroblasts in Duchenne's muscular dystrophy.

Authors:  B B Gelman; M H Davis; R E Morris; E Gruenstein
Journal:  J Cell Biol       Date:  1981-02       Impact factor: 10.539

8.  A protein anomaly in erythrocyte membranes of patients with Duchenne muscular dystrophy.

Authors:  D F Wallach; S P Verma; W E Singer
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

9.  Multi-Compartment, Early Disruption of cGMP and cAMP Signalling in Cardiac Myocytes from the mdx Model of Duchenne Muscular Dystrophy.

Authors:  Marcella Brescia; Ying-Chi Chao; Andreas Koschinski; Jakub Tomek; Manuela Zaccolo
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.